Cargando…
A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease involving both upper and lower motor neurons, leading to paralysis and eventually death. Symptomatic treatments such as inhibition of salivation, alleviation of muscle cramps, and relief of spasticity and pain still play...
Autores principales: | Xu, Xiaojiao, Shen, Dingding, Gao, Yining, Zhou, Qinming, Ni, You, Meng, Huanyu, Shi, Hongqin, Le, Weidong, Chen, Shengdi, Chen, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353789/ https://www.ncbi.nlm.nih.gov/pubmed/34372914 http://dx.doi.org/10.1186/s40035-021-00250-5 |
Ejemplares similares
-
Paraneoplastic Amyotrophic Lateral Sclerosis: Case Series and Literature Review
por: Yang, Zhao, et al.
Publicado: (2022) -
Bone Marrow Stromal Cell Antigen 2: Is a Potential Neuroinflammation Biomarker of SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis in Pre-symptomatic Stage
por: Xu, Xiaojiao, et al.
Publicado: (2022) -
Genetics of amyotrophic lateral sclerosis: an update
por: Chen, Sheng, et al.
Publicado: (2013) -
Current view and perspectives in amyotrophic lateral sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2017) -
Fingerprint analysis of Huolingshengji Formula and its neuroprotective effects in SOD1(G93A) mouse model of amyotrophic lateral sclerosis
por: Zhou, Qinming, et al.
Publicado: (2018)